Insulin prices have been rising — increases that mean some people are spending as much on monthly diabetes-related expenses as their mortgage payment.
As a result, the companies that make insulin have been under fire from the public and politicians including US Senator Bernie Sanders.
In response, one of those insulin-makers, Danish pharmaceutical company Novo Nordisk, said Thursday that it’s partnered with CVS Caremark to provide $25 vials of insulin, roughly $100 less than the list price.
